Skip to main content
    C

    Cogent Biosciences Inc (COGT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.85
    +0.41 (+1.49%)

    Market Cap: $4.97B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Cogent Biosciences Inc (COGT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Cogent Biosciences (COGT) has a latest price of $27.85 on Nov 17, 2026, 36.3% below its 52-week high of $43.73. Its price fell 17.0% over the past 12 months. The month-end price fell 30.2% since Mar 2018, a compound annual decline of 4.1%.

    Price Chart

    From Mar 2018 to Oct 2026, its highest month-end close was $67.08 in Jul 2018 and its lowest $1.65 in Mar 2020, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart COGT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for COGT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 24.4%, and over 6 months it fell 10.9%. The month-end price rose 280.1% over the 3 years through Oct 2026, a compound annual rate of 56.1%.

    PeriodChange
    1 month-7.2%
    3 months-24.4%
    6 months-10.9%
    12 months-17.0%
    12 months, with dividends-17.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+280.1%+56.1%
    5 years+265.8%+29.6%
    Since Mar 2018-30.2%-4.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 355.4%, and its weakest was 2019, when it fell 83.6%.

    YearCloseChange
    2026 through Oct 2026$31.02-12.7%
    2025$35.52+355.4%
    2024$7.80+32.7%
    2023$5.88-49.1%
    2022$11.56+34.7%
    2021$8.58-23.6%
    2020$11.23+289.9%
    2019$2.88-83.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 10.4% below its 50-day average of $31.10 and 20.9% below its 200-day average of $35.21.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$27.85
    52-week high$43.73-36.3%
    52-week low$27.23+2.3%
    50-day average$31.10-10.4%
    200-day average$35.21-20.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 67.3%.

    MeasureValue
    1-year beta1.36
    Largest fall, 1 year-35.9%
    Largest fall, 3 years-67.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About COGT

    What is COGT's 1-year price change?

    Cogent Biosciences's price fell 17.0% over the past 12 months. With dividends included, the 12-month total return was -17.0%.

    What is COGT's 5-year price change?

    Cogent Biosciences's month-end price rose 265.8% over the 5 years through Oct 2026, a compound annual rate of 29.6%. These figures leave out dividends.

    What is COGT's 52-week high and low?

    Cogent Biosciences's 52-week high is $43.73 and its 52-week low is $27.23. Its latest price of $27.85 on Nov 17, 2026 is 36.3% below the high.

    What is COGT's beta?

    Cogent Biosciences's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 35.9%.

    Is the COGT chart free?

    Yes. Advanced Charting for COGT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.